Twitter Logo Youtube Circle Icon LinkedIn Icon

United States > Dispute resolution > Product liability, mass tort and class action: pharmaceuticals and medical devices - defense > Law firm and leading lawyer rankings

Editorial

Index of tables

  1. Product liability, mass tort and class action: pharmaceuticals and medical devices - defense
  2. Hall of Fame
  3. Leading lawyers
  4. Next generation lawyers

Leading lawyers

  1. 1

Who Represents Who

Find out which law firms are representing which Product liability, mass tort and class action: pharmaceuticals and medical devices - defense clients in United States using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact david.burgess@legal500.com.

CLICK HERE TO VISIT THE WHO REPRESENTS WHO SITE

Led by Anand Agneshwar in New York and Pamela Yates in Los Angeles, the practice at Arnold & Porter is at the forefront of pharmaceuticals and medical devices litigation, as evidenced by its involvement in the recent landmark Bristol-Myers Squibb personal jurisdiction decision, in which the United States Supreme Court rejected plaintiffs’ attempts to bring in out-of-state claims related to the Plavix product liability litigation; led by Agneshwar, the team continues to act as national counsel for BMS and its joint venture partner Sanofi in all related litigation, involving claims that the blood thinning medication led to serious injuries and death. In other work, the team successfully defended Endo Pharmaceuticals subsidiary Auxilium in the first bellwether trial of the MDL involving testosterone replacement therapy Testim. The firm’s client roster also includes Pfizer, Bayer and Vintage. Washington DC-based trial and appellate expert William Hoffman is also recommended.

DLA Piper LLP (US)’s pharmaceutical and medical device practice is jointly headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and handles sector-related product liability litigation and mass torts. Williams and New York-based Loren Brown continue to act as national counsel for Novo Nordisk in all litigation arising from claims alleging that some type 2 diabetes treatments can cause pancreatic cancer and pancreatitis. In other ongoing work, Brown defends Pfizer in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. Together with Boston-based Matthew Holian, Brown also represents Bristol-Myers Squibb and Pfizer in an MDL involving claims that anticoagulant medication Eliquis causes bleeding. Bayer, Medtronic and Biogen are also clients of the firm. Cara Edwards in New York is another name to note and Boston-based Jessica Wilson was invited to partnership in January 2017.

Goldman Ismail Tomaselli Brennan & Baum LLP’s products liability practice ‘provides stellar defense in drug and medical device cases’. The team is headed by Tarek Ismail and ‘combines strong analytical strategic planning and execution with trial skills’. Led by the highly recommended Shayna Cook, the team represents Bayer in two MDLs related to the contraceptive system Mirena, involving claims that the device causes a variety of injuries, headaches and vision loss. In other work, the practice acts as trial counsel to Johnson & Johnson and its subsidiary Ethicon across several cases in the transvaginal mesh product liability litigation and recently defended the client in Rocio Herrena-Nevarez v Ethicon, where the plaintiff alleged that the device caused permanent injuries. The firm’s client base also includes Medtronic and Merck. Dallas-based Joe Tomaselli and Rami Fakhouri in Chicago are ‘practical, thorough, sharp and well-prepared’ and Jennifer Greenblatt is also highly recommended. All named partners are based in Chicago, unless otherwise noted.

Trusted Advisor - with Finnegan

IP specialist Finnegan detail how their collaborative approach makes for a unique culture which is designed to allow them to work with clients in a way which is cognizant of the challenges facing all companies today.

Reed Smith LLP’s pharmaceuticals and medical device litigation practice is headed by Melissa Geist in Princeton, who is also co-chair of the firm’s life sciences health industry group. The team handles MDLs and class actions for well-known manufacturers in the pharmaceuticals sector and regularly acts as coordinating, trial and litigation counsel in high-stakes matters across the country. Philadelphia-based Barbara Binis and Michael Brown in Los Angeles are other key figures. The New York office suffered the departure of John Hooper, Eric Gladbach, Kelly D’Auria and Jacqueline Seidel to King & Spalding LLP in July and in June 2017, Amy Vanni and Russell Gaudreau departed to McCarter & English, LLP and Greenberg Traurig, LLP, respectively.

The ‘strategic and smart’ team at Washington DC-based Williams & Connolly LLPis at the top of its game and among the best of the best in this practice area’. Co-head Joseph Petrosinelli is ‘particularly good at seeing the big picture’ and co-heads the department with Heidi Hubbard. Paul Boehm stands out as a ‘top-notch trial and strategic litigation talent’. The team regularly acts as lead national counsel, trial and resolution counsel for manufacturers in the pharmaceuticals and medical devices industry. Petrosinelli and the ‘superb’ John Joiner continue to act as national counsel to Pfizer in an MDL involving cases alleging that the client’s Viagra caused plaintiffs to develop melanoma. Led by Stephen Raber, the team continues to represent Bristol-Myers Squibb in MDL cases alleging that diabetes treatments Farxiga and Xigduo cause diabetic ketoacidosis and acute kidney injury, and recently obtained dismissal of six related cases. Merck, Bayer and Medtronic are also clients of the firm. Senior counsel Douglas Marvin is another name to note.

Bartlit Beck Herman Palenchar & Scott LLP’s trial practice has vast experience acting for manufacturers in the pharmaceuticals and medical device sectors. Led by Kaspar Stoffelmayr, the team acts as national counsel and lead trial counsel for Bayer in an MDL in Illinois and other lawsuits related to claims alleging that oral contraceptives Yaz and Yasmin cause a variety of injuries, including thrombosis, pulmonary embolism, heart attacks and strokes. Together with Steven Derringer, Stoffelmayr also continues to represent the client in product liability litigation related to the pharmaceutical Xarelto. In another highlight, Rebecca Bacon continues to defend Endo Pharmaceuticals in a testosterone replacement therapy case involving testosterone gel Testim. The firm’s client roster also includes NL Industries, Du Pont and United Technologies. Other names to note are John Fitzpatrick and Philip Beck. All named partners are based in Chicago.

The product liability and class actions practice at Bowman and Brooke LLP is headed by Minneapolis-based Kim Schmid and was bolstered by the September 2017 hire of senior counsel Erica Mekles from K&L Gates and Christopher Carton, in course of the opening of a new office in Newark. The team is recommended for its ‘superior work at every stage of litigation’ and continues to act as national product liability counsel to Siemens Medical Solutions. In Austin, the recommended Randall Christian and Mary Pawelek lead the defense for the sales representatives of Daiichi Sankyo in the Benicar litigation, involving claims that the blood pressure treatment medication causes sprue-like enteropathy. The Hanover Insurance Group, Novo Nordisk and Smiths Group are also clients of the firm. Austin-based Damon Brinson, William Childs and John Garrett, and Minneapolis-based Sheryl Bjork were promoted to partnership in January 2018.

Butler Snow LLP’s pharmaceutical, medical device and healthcare practice group is led by Alyson Jones in Jackson. The ‘knowledgeable, dedicated and hardworking’ team regularly handles sector-related mass torts and MDLs and stands out with extensive trial expertise. New York-based David Cohen is ‘a gifted lawyer who specializes in Daubert issues at the intersection of law and medicine’ and the ‘client-focused and strategic’ Eric Hudson in Memphis is another name to note. Led by recommended Jackson-based of counsel Christy Jones and William Gage, the team continues to act as national coordinating counsel for Johnson & Johnson and Ethicon in the Ethicon Inc. Pelvic Repair System Products Liability Litigation and serves as trial counsel in several related lawsuits. In other work, the team represents Merck as national counsel in a product liability litigation involving hair loss drug Propecia, in which plaintiffs allege failure to warn users of sexual dysfunction caused by the drug. The firm’s client roster also includes Takeda, Merck and Hoffmann-La Roche.

The pharmaceutical, medical device and healthcare litigation practice at Greenberg Traurig LLP is headed by Atlanta-based Lori Cohen and is recommended for its ‘expertise in medical device product liability cases and the pharmaceuticals industry generally’. Led by Chicago-based Gregory Ostfeld and Christiana Jacxsens in Atlanta, the team continues to act as lead national counsel to Alcon in six multi-state consumer fraud class actions and recently obtained dismissal of the first and lead case, in which plaintiffs had alleged unfair practices in the dropper design of glaucoma drugs. In other work, Cohen acts as national counsel to Medtronic in litigation and claims involving a wide variety of medical devices and recently obtained settlements in three cases with significant potential exposure. The team also continues to represent CR Bard as national coordinating and national trial counsel in all claims concerning pelvic mesh and vaginal mesh devices. Sandoz, Takeda and Teva are also clients of the firm. In June 2017, mass torts expert Russell Gaudreau joined the New York office from Reed Smith LLP.

Hughes Hubbard & Reed LLP’s product liability and toxic tort group advises manufacturers on pharmaceuticals and medical devices litigation and has ‘built a mosaic of capabilities in a wide range of activities that is designed to offer a multinational client a wall-to-wall service’. The practice is co-headed by Diane Lifton and Robb Patryk. Led by Patryk and the recommended Theodore Mayer, the team continues to act as national coordinating counsel for long-time client Pfizer in diet drugs litigation and obtained dismissal of three related cases. In other ongoing work, Los Angeles-based David Stern defends Fresenius in litigation involving claims alleging lack of adequate warning about the risk of heart problems from dialysis products GranuFlo and NaturaLyte. The ‘productive and constructiveCharles Cohenis extremely capable in handling disclosure matters’ and James Fitzpatrickhas cutting-edge abilities on the scientific aspects’. All named partners are based in New York, unless otherwise stated.

The life sciences and healthcare practice group at King & Spalding LLP is co-headed by Atlanta-based Andrew Bayman and Bruce Hurley in Houston. Led by Bayman, the team continues to represent GlaxoSmithKline (GSK) as national counsel in litigation related to the anti-depressant medication Paxil, which involves allegations that the use of the drug during pregnancy causes congenital defects. In other work, Hurley and Houston-based Tracie Renfroe continue to represent Johnson & Johnson in hip implant litigation including an MDL, in which plaintiffs allege defective design, defective manufacturing and failure to warn. Merck, Bristol-Myers Squibb and Eli Lilly are also clients of the firm. In April 2017, the Austin office was strengthened with the hire of Lana Varney, Stephen Huffaker and Lisa Shub from Norton Rose Fulbright US LLP, and in July 2017, Eric Gladbach, Kelly D’Auria and Jacqueline Seidel joined from Reed Smith LLP. Shawn Stephens and Dan Willoughby retired and Halli Cohn joined Troutman Sanders in July 2017. Senior counsel Chilton Varner in Atlanta is another name to note.

Washington DC-based Paul Zevnik heads the product liability, tort and insurance practice at Morgan, Lewis & Bockius LLP and Philadelphia-based John Lavelle leads the pharmaceutical and medical device practice group. Led by Lavelle and Bernard Garbutt in New York, the team successfully defended Medtronic in the personal injury and product liability lawsuit Babayev v Medtronic, in which the plaintiff alleged that he sustained electric shock injuries after the implantation of a neuro-stimulator. In another highlight, Lavelle obtained dismissal of the high-profile lawsuit Caltagirone v Cephalon brought against clients Teva and Cephalon, involving off-label marketing claims related to opiate painkiller Actiq. The firm’s client base also includes Janssen Pharmaceuticals and Baxter. Ethel Johnson in Houston, Los Angeles-based Yardena Zwang-Weissman and David Luttinger in New York are other key figures. In July 2017, Wendy Feinstein joined the Pittsburgh office from Eckert Seamans Cherin & Mellott, LLC.

Nina Gussack heads the health sciences department at Pepper Hamilton LLP, that regularly represents pharmaceutical and medical device manufacturers in product liability litigation and class actions. Led by Gussack and Sean Fahey, the team continues to act as national counsel to Eli Lilly in several product liability lawsuits, including the Byetta MDL, which involves claims that the type 2 diabetes treatment causes acute pancreatitis, pancreatic cancer, renal failure or thyroid cancer. In other work, Gussack is national settlement counsel for Bard in the pelvic repair system MDL, in which plaintiffs allege injuries caused by the transvaginal mesh implants. GlaxoSmithKline, Medtronic, Merck and Johnson & Johnson are also clients of the firm. Andrew Kantra is another key figure. In November 2017, Rachael Bushey returned to the firm from Hogan Lovells US LLP. The Berwyn office was strengthened with the October 2017 arrival of Deborah Spranger from Saul Ewing. All partners are based in Philadelphia, unless otherwise stated.

Headquartered in Philadelphia, the team at Quinn Emanuel Urquhart & Sullivan, LLP has a strong track record representing manufacturers in life sciences-related mass torts and product liability litigation. The firm acted as co-national counsel for Purdue Pharma in litigation concerning its prescription opioid pain medications, such as OxyContin, involving misleading marketing claims. In other work, the team successfully defended longstanding client Pfizer in product liability litigation concerning antidepressant Zoloft, in which plaintiffs had alleged that the use of the drug during pregnancy caused children to be born with birth defects. Sandra Bresnick and Washington DC-based Michael Lyle are other key contacts in the department. Faith Gay left the firm in January 2018 to found a new firm. In May 2018, Sheila Birnbaum and Mark Cheffo moved to Dechert LLP.

Shook, Hardy & Bacon LLP’s pharmaceutical and medical device practice is headed by Alicia Donahue in San Francisco and handles sector-related product liability litigation, class actions and mass torts. In one highlight, Miami-based Daniel Rogers and William Geraghty acted as co-counsel to Amgen, Pfizer and Wyeth in litigation concerning its biologic drug Enbrel, involving claims alleging failure to warn; in 2018, the United States Court of Appeals for the Eleventh Circuit affirmed summary judgment in favor of the manufacturers. In other work, Houston-based James Shepherd successfully represented Bayer on appeal and in district court in relation to the Mirena IUD MDL. Together with Kansas City-based Jon Strongman, Rogers also defended Boston Scientific in transvaginal surgical mesh litigation, in which the plaintiff alleged failure to warn. Johnson & Johnson, Allergan and Bausch & Lomb are also clients of the firm.

Washington DC-based John Beisner heads the mass torts, insurance and consumer litigation practice at Skadden, Arps, Slate, Meagher & Flom LLP, that is also active in the pharmaceuticals and medical devices industry. Together with Jessica Miller, also based in Washington DC, Beisner continues to represent Johnson & Johnson in recently centralized lawsuits concerning baby powder that is allegedly toxic and causes ovarian cancer. In other work, Miller, Allen Ruby in Palo Alto and Lisa Gilford in Los Angeles continue to represent robotic medical device manufacturer Intuitive Surgical in several product liability lawsuits, involving a variety of personal injury and wrongful death claims. The team also handles discovery for J&J subsidiary Ethicon in the Gynecare pelvic mesh product MDL. Other clients include Merck and Pfizer.

The product liability practice at Venable LLP is jointly headed by Paul Strain and Sally Bryan in Baltimore, and is particularly active in product liability litigation and class action defense in the pharmaceuticals area. Recent work includes acting as co-national counsel to Takeda in the proton pump inhibitor (PPI) MDL, in which plaintiffs allege kidney injuries caused by the medication. The team also acts as co-counsel for AbbVie in the Depakote cases and, led by Strain, David Heubeck and Stephen Marshall, continues to represent Merck in the ongoing Fosamax litigation, involving claims alleging that the osteoporosis drug causes bones in the jaw to deteriorate. Edward Boyle and Angel Garganta co-head the class action department in New York and San Francisco, respectively.

Headed by Stephen Strauss, the St Louis-based product liability team at Bryan Cave Leighton Paisner LLP is experienced in pharmaceuticals and medical devices-related class actions and personal injury lawsuits. In one recent highlight, the team successfully defended Merck against three putative class actions concerning the client’s glaucoma medication. In other work, Bettina Strauss continues to advise Johnson & Johnson on pelvic and hernia mesh cases across the country and leads the defense of the West Virginia pelvic mesh MDL cases in Kansas and Missouri. Dan Ball and Robert Ebert are also active in the sector.

The ‘knowledgeable’ team at Dechert LLP defends pharmaceutical and medical devices manufacturers in product liability litigation and consumer fraud claims. Led by Philadelphia-based Hope Freiwald, the team continues to represent AbbVie in national product liability litigation involving testosterone replacement therapy AndroGel, which allegedly causes a variety of injuries, including pulmonary embolism. The team is headed by William Oxley in Los Angeles. Philadelphia-based Ben Barnett and Nathan Hoffman in Chicago also active in the department. In May 2018, Sheila Birnbaum, Mark Cheffo and Douglas Fleming joined the firm’s New York office from Quinn Emanuel Urquhart & Sullivan, LLP.

Headed by Joanne Gray in New York, Goodwin’s product liability and mass torts litigation practice is particularly experienced in trial work and risk mitigation. In one recent highlight, Boston-based Richard Oetheimer obtained a conditional national settlement of several thousand metoclopramide cases filed against longstanding client Teva Pharmaceuticals. In New York, Glenn Kerner continues to represent Teva in a product liability lawsuit, in which the plaintiff claims that her husband suffered catastrophic injury as a result of exposure to the client’s anesthesia Propofol. Sarah Frederick in Boston is another key figure in the department.

Hogan Lovells US LLP’s product litigation practice is headed by Lauren Colton in Baltimore and advises manufacturers in the pharmaceuticals and medical devices industry on product liability lawsuits, MDLs and regulatory matters. Together with Minneapolis-based senior counsel Mitchell Zamoff, Colton successfully defended Medtronic in a lawsuit brought by Humana, alleging that the manufacturer had fraudulently manipulated medical literature regarding its Infuse bone graft device. In other work, the team continues to act as co-national coordinating counsel to Bristol-Myers Squibb in litigation concerning its antipsychotic Abilify. The firm’s client roster also includes Amgen, Zimmer and Baxter. In course of the September 2017 combination with Collora LLP, Maria Durant and Sara Silva joined the firm with a new Boston office. Rachael Bushey returned to Pepper Hamilton LLP in November 2017.

Jones Day’s business and tort litigation and product liability practice is headed by Atlanta-based Stephanie Parker and is regularly involved in high-profile lawsuits in the pharmaceutical and medical devices sector. Led by José Isasi in Chicago, the team represents Abbott Laboratories in a personal injury action involving an allegedly defectively manufactured medical device. In other work, Cleveland-based David Alden defends Indivior against a wrongful death claim, in which plaintiffs allege lack of adequate warnings in Suboxone, a maintenance treatment for patients addicted to opioids. AbbVie, Merck and Takeda are also clients of the firm. Chicago-based Daniel Reidy is another key contact.

The department at Kirkland & Ellis LLP regularly handles product liability and mass tort litigation for pharmaceutical and manufacturing companies. Led by Washington DC-based Paul Clement, the team represents Johnson & Johnson and its affiliate DePuy Orthopedics in the consolidated appeals of an adverse jury verdict related to a hip prosthetics MDL, in which plaintiffs allege that the implants cause serious health issues. In other work, the team assists longstanding client Teva Pharmaceuticals with product liability lawsuits and class actions. The firm’s client base also includes GlaxoSmithKline, Abbott and AbbVie. Robert Brock in Washington DC and New York-based Jay Lefkowitz are other key figures.

Mayer Brown’s ‘excellent’ life sciences litigation team is jointly headed by Henninger Bullock in New York and Chicago-based Michael Olsen and Daniel Ring, who is particularly experienced in medical device litigation. Together with Washington DC-based ‘pre-emption expertAndrew Tauber, who is recommended for his ‘great depth of knowledge’, Ring continues to act as national pre-emption counsel for Medtronic in relation to nationwide product liability litigation involving the client’s Infuse bone-graft device, and recently obtained dismissal of several related lawsuits. St Jude Medical, Abbott Laboratories and Eli Lilly are also part of the firm’s client roster.

The ‘knowledgeable’ Erin Bosman heads the San Diego-based product liability team at Morrison & Foerster LLP, which regularly acts as counsel and trial team for manufacturers in the pharmaceutical and medical devices sectors. Ongoing work includes representing McKesson in product liability cases related to a number of medications, including Taxotere and Reglan. Together with Julie Park, Bosman also acts as national product liability counsel to MicroPort Orthopedics. Other clients include Fitbit and Fresenius. Park was invited to partnership in January 2017.

Norton Rose Fulbright US LLP’s products, pharma, medical and mass tort practice is led by Steven Jansma in San Antonio and handles contentious and non-contentious sector-related work, such as risk mitigation, discovery and litigation. In one recent highlight, Dallas-based Jonathan Skidmore obtained a complete defense verdict for Zimmer Biomet Holdings in a product liability trial, in which the plaintiff alleged that she suffered personal and economic injuries from a hip replacement device manufactured by the client. In Austin, Stacey Martinez achieved summary judgment for all remaining claims against client GlaxoSmithKline in the Poligrip MDL. Bayer and Coloplast are also clients of the firm. In April 2017, Lana Varney, Stephen Huffaker and Lisa Shub departed to King & Spalding LLP.

O'Melveny & Myers LLP defends high-profile manufacturers in the pharmaceuticals and medical devices industries in class actions and product liability litigation. Led by San Francisco-based Matt Powers, Los Angeles-based Richard Goetz and Allen Burton in New York, the team recently obtained dismissal of a nationwide class action for longstanding client Johnson & Johnson, concerning the allegedly toxic Baby Powder. In other work, the practice continues to defend J&J and its subsidiary Janssen Pharmaceuticals in actions and investigations by a variety of government entities, in regards to alleged deceptive marketing of opioid painkillers. The firm’s client roster also includes Ethicon and Endo Pharmaceuticals. The department is led by Steve Brody in Washington DC.

Los Angeles-based Mollie Benedict heads the medical device and pharmaceutical liability practice at Tucker Ellis LLP, which has a strong track record acting as national coordinating counsel in sector-related MDLs and class actions. Led by Cleveland-based John Lewis and Dustin Rawlin, the team continues to act as national coordinating and lead counsel for Johnson & Johnson subsidiary Mentor Worldwide in litigation involving its transvaginal mesh products and breast implants. J&J subsidiaries Ethicon and Janssen Pharmaceuticals are also clients of the firm. Rita Maimbourg, also based in Cleveland, leads the wider trial department.

The ‘excellent’ Denver-based practice at Wheeler Trigg O'Donnell LLP has ‘a deep level of expertise defending product liability, mass tort, pharmaceuticals and medical device cases’. Habib Nasrullah continues to act as national settlement counsel for longstanding client McKesson regarding all litigation involving chemotherapy drug Taxotere, which allegedly causes permanent hair loss in cancer patients. Department head Michael O’Donnell is recommended for his ‘tremendous practical judgment and excellent advocacy skills’.

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to